Advances in Primary and Secondary Bone and Soft Tissue Tumors
A special issue of Cancers (ISSN 2072-6694).
Deadline for manuscript submissions: 31 May 2026 | Viewed by 11
Special Issue Editor
2. Rhein-Main Sarcoma Center at University Cancer Center, University Medical Center of Mainz, Mainz, Germany
Interests: orthopedic surgery; orthopedic oncology; bone sarcoma; soft tissue sarcoma; pathological fractures; metastatic disease; benign bone tumours and tumour-like lesions; osteology; benign soft tissue tumors
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
This Special Issue aims to highlight recent advances in the understanding, diagnosis, and treatment of bone and soft tissue tumors, including both primary and metastatic disease. We invite contributions covering basic (laboratory-based) science, translational research, and clinical investigations. Topics of interest include molecular and cellular mechanisms of tumor initiation, progression, and metastasis; innovations in imaging and diagnostic methods; advances in surgical, systemic, and targeted therapies; and the integration of immunotherapy and precision medicine. Submissions that bridge fundamental research and clinical application are particularly encouraged, with the goal of improving outcomes for patients with these challenging malignancies.
Prof. Dr. Frank Traub
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- primary bone tumors
- soft tissue sarcomas
- metastatic bone disease
- molecular diagnostics including liquid biopsy
- surgical management including reconstruction
- immunotherapy
- tumor microenvironment
- biomarkers and prognostic factors
- cancer surveillance
- translational oncology
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
